Investment to Drive CRO’s Development in Europe, North America and Asia
Mar 16 2020 Read 567 Times
Clinical research organisation Banook Group has announced new funding from Turenne Santé, via the FPCI Capital Santé 2. The transaction places the investor, along with Banook founder Pascal Voiriot and senior management representatives, as the driving force behind plans for further development in Europe, North America and Asia, with the company aiming for ISO certification by the beginning of 2021. Euro Capital, based in Metz, advised by Turenne Group and the ILP funds, based in Nancy, have also invested.
Founded in 1999 the Banook Group works with pharmaceutical and biotech companies, CROs, non-profit organisations and academic centres involved in phase 1-3 clinical trials, prior to new medication approval. It helps companies that develop new ECG tracing recording devices to validate their algorithm.
According to the group’s estimates, the cardiac safety and imaging segment represented around $140 million (€123M) in 2017. It is estimated that the global CRO market should represent nearly $44 billion (€39bn) in 2021.
Pascal Voiriot and Alexandre Durand-Salmon, respectively president and CEO of the Banook Group, said: “This operation is an important step in the acceleration of our development. The Banook Group places great importance in the improvement of the quality of life of millions of patients throughout the world. This is reflected in the company culture and our commitment to bringing science closer to people. We are excited to embark on this ambitious journey with our new partners.”
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Export experts talk Corona Virus - Automated cell counting shouldn’t cost the earth Laboratory Products - Spectrophotometer Linearity Validation - Analysi...
View all digital editions
May 31 2020 Houston, TX, USA
May 31 2020 Baltimore, MD, USA
Jun 11 2020 Brussels, Belgium
Jun 20 2020 San Diego, CA, USA
Jun 30 2020 Nuremberg, Germany